Marcos Gil Garcia

Dr. Marcos Gil Garcia is a Researcher at the Institute for Chemical and Bioengineering (ICB) within the Department of Chemistry and Applied Biosciences at ETH Zürich. His work focuses on biochemical engineering, protein design, and biomolecular condensates. He holds a Ph.D. and has extensive experience in developing therapeutic protein-based nanomaterials and studying neurodegenerative biomarkers through extracellular vesicles. His research integrates structural biology, biophysics, and computational approaches to address challenges in protein aggregation and functional amyloids.

Key research areas include:

• Biomolecular condensates and their role in enzymatic activity modulation
• Design of protein nanoparticles for targeted therapies
• Cryo-EM structural analysis of amyloid fibrils in diseases
• Engineering soluble proteins through computational redesign

Publications highlight advancements in phase-separated systems, functional amyloids, and therapeutic applications of coiled-coil proteins. His work bridges fundamental biochemistry with translational nanotechnology, contributing to fields like cancer immunotherapy and neurodegenerative disease diagnostics.